Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
Cost Savings on Generic Drugs: Transparent Pric...
By
Staff Writer
June 18, 2024
Introduction Through its transparent, online direct-to-consumer pharmacy model, the Mark Cuban Cost Plus Drug Company (MCCPDC) has made substantial progress in the provisi...
The Economic Burden of Knee Arthroplasty Revisions: A Cost Analysis from Türkiye
The Impact of Time Horizons on QALY Calculations in Healthcare
The Power of Real-World Evidence: Bringing Everyday Health Data to Drug Appro...
Healthcare Decision-Making with MCDA Framework: The Saudi Arabian Perspective
Prevention is Better Than Cure: The Costs of the Pandemic Accord
Economic Evaluations for Dementia Interventions
Health equity insights for National Cancer Survivors Day
An Era of Equitable Access: The Potential of the Pandemic Accord
Balancing the scales: An inclusive framework for equity in Multi-Cancer Early...
How User-Centered Perspectives Foster Innovation in Digital Health Surveillan...
Quality-Adjusted Life Year (QALY) in Modern Healthcare Decision-Making
Namibia Mother-to-Child Transmission Elimination of HIV & Hep B
« Previous
1
…
25
26
27
28
29
…
40
Next »